 - A relapsing-remitting course of disease with at least 1 documented relapse during the previous year, or 2 documented relapses during the previous 2 years, or a positive gadolinium Gd-enhanced MRI scan at screening in case the first MRI scan obtained at screening is negative, a second scan may be obtained 1 month later. 